(RTTNews) - Novo Nordisk A/S (NVO) and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (1276.HK) announced Tuesday that they have entered into an exclusive license agreement for HRS-1596, a Phase 1-ready GLP-1/GIP dual receptor agonist with potential for once-weekly oral dosing.
(RTTNews) - Neurocrine Biosciences, Inc. (NBIX) announced that Eiry W. Roberts will return as Chief Medical Officer, effective immediately, succeeding Sanjay Keswani, who will depart the company by mutual agreement.
(RTTNews) - Ascletis Pharma Inc. (1672.HK) reported positive Phase 1 results for ASC50 in plaque psoriasis, with the investigational oral therapy showing a 48.9% placebo-adjusted reduction in PASI score after 28 days of treatment.
(RTTNews) - FMC Corp. (FMC), an agricultural sciences company, announced the submission of the regulatory dossier for rimisoxafen, an herbicide active ingredient, to Brazilian regulatory authorities.
(RTTNews) - Corteva, Inc. (CTVA) and Inari, the SEEDesign company, have reached a confidential settlement agreement to resolve a lawsuit filed by Corteva in September 2023 in the U.S. District Court for the District of Delaware.
(RTTNews) - Stock markets in Europe are expected to open on a mildly positive note on Tuesday. However, sentiment is likely to be impacted by the surge in crude oil prices and the spike in bond yields. Worries about artificial intelligence is also expected to weigh on sentiment.